Medical/Pharmaceuticals

Fosun International Wins Platinum Award at The Asset ESG Corporate Awards 2022

HONG KONG, Jan. 26, 2023 /PRNewswire/ -- Fosun International Limited ("Fosun International" or the "Company") (HKEX: 00656) was informed byThe Asset, the renowned international asset management and investment magazine, that Fosun has garnered the Platinum Award at The Asset ESG Corporate Awards 2...

2023-01-26 14:59 4166

Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue in 11 countries, only 1 year after approval in Korea

"Expected to change GERD drug market landscape" * Application for product approval of Fexuclue, a new drug for gastroesophageal reflux disease (GERD), has been completely submitted toColombia ,Vietnam, and Saudi Arabia * NDA submissions in 11 countries completed in the shortest time among K...

2023-01-26 09:14 2777

GenKOre Announces Collaboration with a US-based Company on In vivo Gene-editing Therapy

SEOUL, South Korea, Jan. 26, 2023 /PRNewswire/ -- GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, announced that it has entered into a strategic research collaboration with a US-based biopharma company for the development of in vivo  gene editing therapies. This c...

2023-01-26 09:00 3303

MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study

GENEVA, Jan. 26, 2023 /PRNewswire/ -- The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US inOctober 2022. SELUTION ...

2023-01-26 08:00 2740

Correction - Health in Transportation Releases New Smartphone Face-Scanning Application Aimed at Uncovering Potentially Serious Health Concerns in Professional Drivers

Correction Notice Please note the following corrections to the Press Release issued Jan 17, 2023 : * The CDL Health Scanner is a product of Health in Transportation. NuraLogix does not hold any liability for any applications distributed under the Health in Transportation name. * Nur...

2023-01-26 05:30 2303

Breg Partners with Correal International to Provide Orthopedic Products to Physicians & Patients in China

CARLSBAD, Calif., Jan. 26, 2023 /PRNewswire/ -- Breg, Inc., a leading orthopedic bracing and billing services company, announced today that it has partnered with medical device supplier Coreal International to bring its broad portfolio of bracing and cold therapy products to Chinese physicians an...

2023-01-26 04:54 2888

CO.DON finally saved - investor has taken over the business operations of the Leipzig-based biopharmacy company with an additional location in Teltow, Brandenburg.

CO.DON continues business operations as a GmbH (limited liability company) LEIPZIG and TELTOW, GERMANY, Jan. 26, 2023 /PRNewswire/ -- With effect from 20.01.2023, CO.DON's business activities will be continued in the legal form of a GmbH (limited liability company) following a transferring reorga...

2023-01-26 01:30 2343

PlumCare RWE partners with Lifebit on Greece's newborn genomic sequencing program, BeginNGS

* PlumCare RWE and Lifebit enter a three-year partnership to support Greece's pioneering national newborn genomic sequencing program, BeginNGS. * Researchers will be able to access and analyse data securely in combination with global cohorts, whilst ensuring data is kept safe, private and in p...

2023-01-25 23:00 3074

Malaysia Healthcare Partners with AirAsia

Cambodian Passengers Can Kickstart 2023 with Wellness Travel to Malaysia PHNOM PENH, Cambodia, Jan. 25, 2023 /PRNewswire/ -- In its pursuit to providing accessible preventive healthcare and wellness options for global citizens, Malaysia Healthcare Travel Council (MHTC) partners with AirAsia, off...

2023-01-25 14:05 3295

DiscGenics Announces Positive Two-Year Clinical Data from U.S. Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of life, and pain medication usage out to two years post-injection in patients with lumbar DDD. SALT LAKE CITY, Jan. 25, 2023 /PRNewswire/ -- DiscGenics, I...

2023-01-25 08:35 2516

Metabolon Secures $25 Million of Funding to Accelerate Growth

MORRISVILLE, N.C, Jan. 24, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications, today announced that it has closed on$25 million of additional ...

2023-01-24 21:07 2391

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

ADELAIDE, Australia, Jan. 23, 2023 /PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a furtherA$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal...

2023-01-23 05:00 6434

A Healthy Winter Action: Second Batch of 19,600 Bottles of Azvudine Delivered to 24 Counties

COVID-19 Prevention and Treatment Live-Streaming Training for Rural Doctors Attracted over 1 Million Views HONG KONG, Jan. 20, 2023 /PRNewswire/ -- On January 16, the second stage of "A Healthy Winter Action" initiated by Fosun Foundation in conjunction with other institutions kicked off, with 1...

2023-01-20 18:12 4888

CNN's 'Vital Signs' explores the potential of medical non-invasive therapeutic technology

HONG KONG, Jan. 20, 2023 /PRNewswire/ -- As the search continues for non-invasive ways to treat neurodegenerative diseases, focused ultrasounds have become an alternative to surgery when it comes to treating essential and Parkinson's tremors. This month on CNN's'Vital Signs'

2023-01-20 15:00 3357

VISTA Eye Specialist to host Eye Health Carnival Nationwide in Malaysia

PETALING JAYA, Malaysia, Jan. 20, 2023 /PRNewswire/ -- In an effort to increase eye health awareness for Malaysians, particularly on the top 3 causes of preventable blindness, VISTA Eye Specialist is excited to announce the return of their Eye Health Carnival nationwide, happening mid-February, 2...

2023-01-20 08:00 3299

Seragon Announces RESTORIN®, the Most Advanced Anti-Aging Nutraceutical to Date

IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging. RESTORIN integrates a series of patented technologies fromHarvard University, Mayo Clinic, and Scripps Research to boost cellular nicotinam...

2023-01-19 23:10 4247

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma's Global Infrastructure to Provide Broad Access to Deuruxolitinib for Patients with Alopecia Areata Strengthens Sun Pharma's Global De...

2023-01-19 23:05 4451

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

LONDON and HONG KONG, Jan. 19, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced an executive leadership change to ensure the company realizes the full potential of its broad genetics and digital testing platform and as a commi...

2023-01-19 18:56 3054

Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets

Funding from MassMutual Ventures, SEEDS Capital, Exfinity Ventures BOSTON, Jan. 19, 2023 /PRNewswire/ -- Qritive (www.qritive.com), a leading healthcare AI startup has announced that they have raised$7.5M in a funding round led by MassMutual Ventures, supported by SEEDS Ca...

2023-01-19 08:15 3482

Innovent Announces Inclusion in the China National Reimbursement Drug List (NRDL) of TYVYT in Two New Indications, Olverembatinib for the First Listing, BYVASDA, HALPRYZA and SULINNO in Multiple New Indications

ROCKVILLE, Md. and SUZHOU, China, Jan. 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...

2023-01-18 21:34 3301
1 ... 142143144145146147148 ... 399